Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

H. G. Schrott, V. Bittner, E. Vittinghoff, D. M. Herrington and S. Hulley
Department of Preventive Medicine, University of Iowa, Iowa City 52242, USA.

OBJECTIVES: To determine the proportion of volunteer women with established heart disease who have low-density lipoprotein cholesterol (LDL-C) levels at or below the National Cholesterol Education Program Adult Treatment Panel goals and to determine what factors are associated with levels above goal or not receiving lipid-lowering medication when indicated. DESIGN: Cross-sectional measurement of lipids and lipoproteins, blood pressure, height, weight, and other demographic and cardiovascular risk factors in 2763 postmenopausal women with heart disease. SETTING: At 18 centers throughout the United States, participants were recruited by means of lists of women with coronary heart disease from coronary units and catheterization laboratories, direct mail to age-eligible women, and advertisements. PATIENTS: Mean age of the cohort was 66.7 years (range, 44-79 years) and the distribution by race/ethnicity was 88.7% white, 7.9% African American, 2.0% Hispanic/Latina, 0.8% Asian/Pacific Islander, and 0.7% other. INTERVENTION: We report cross-sectional analysis of the cohort at baseline. OUTCOME MEASURES: We measured the frequency of achieving 1988 and 1993 Adult Treatment Panel treatment goals, and of being on a regimen of lipid-lowering medication. RESULTS: Although 47% of participants were taking a lipid-lowering medication, 63% did not meet the 1988 treatment goal of LDL-C level less than 3.4 mmol/L (130 mg/dL) and 91% did not meet the 1993 goal of LDL-C level less than 2.6 mmol/L (100 mg/dL). Factors independently associated with achieving the earlier goal were use of lipid-lowering medication, marital status, education, body mass index, exercise, hypertension, diabetes, gallbladder disease, and first diagnosis of coronary heart disease after 1990. Failure to use lipid-lowering medication was associated with age, being African American, marital status, body mass index, lack of exercise, alcohol consumption, current smoking, and first diagnosis of coronary heart disease before 1985. CONCLUSION: The majority of women enrolled in the trial had LDL-C levels that significantly exceeded the treatment goals set by the 1988 and 1993 Adult Treatment Panel guidelines. Better implementation of these guidelines among women with coronary disease would be highly desirable.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy: The CHECK-UP Study: A Randomized Controlled Trial
Grover et al.
Arch Intern Med 2007;167:2296-2303.
ABSTRACT | FULL TEXT  

Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke
Muntner et al.
Am J Epidemiol 2006;163:913-920.
ABSTRACT | FULL TEXT  

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke
Ovbiagele et al.
Neurology 2006;66:1164-1170.
ABSTRACT | FULL TEXT  

Time Course of Rapid C-Reactive Protein Reduction by Pravastatin in Patients with Stable Angina
Li et al.
ANGIOLOGY 2006;57:1-7.
ABSTRACT  

Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease
Berman et al.
JNM 2006;47:74-82.
ABSTRACT | FULL TEXT  

Perspectives on Dyslipidemia and Coronary Heart Disease in Women
Bittner
J Am Coll Cardiol 2005;46:1628-1635.
ABSTRACT | FULL TEXT  

Opportunity for Intervention to Achieve American Heart Association Guidelines for Optimal Lipid Levels in High-Risk Women in a Managed Care Setting
Mosca et al.
Circulation 2005;111:488-493.
ABSTRACT | FULL TEXT  

Is Lipid-Lowering Therapy Underused by African Americans at High Risk of Coronary Heart Disease Within the VA Health Care System?
Woodard et al.
Am. J. Public Health 2004;94:2112-2117.
ABSTRACT | FULL TEXT  

Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
Meagher
J Am Board Fam Med 2004;17:424-437.
ABSTRACT | FULL TEXT  

In-Hospital Initiation of Lipid-Lowering Therapy After Coronary Intervention as a Predictor of Long-term Utilization: A Propensity Analysis
Aronow et al.
Arch Intern Med 2003;163:2576-2582.
ABSTRACT | FULL TEXT  

The Emergence of the Metabolic Syndrome with Menopause
Carr
J. Clin. Endocrinol. Metab. 2003;88:2404-2411.
ABSTRACT | FULL TEXT  

Screening for Statin-Related Toxicity: The Yield of Transaminase and Creatine Kinase Measurements in a Primary Care Setting
Smith et al.
Arch Intern Med 2003;163:688-692.
ABSTRACT | FULL TEXT  

Risk Factors and Secondary Prevention in Women with Heart Disease: The Heart and Estrogen/progestin Replacement Study
Vittinghoff et al.
ANN INTERN MED 2003;138:81-89.
ABSTRACT | FULL TEXT  

Patient Factors and Medication Guideline Adherence Among Older Women With Asthma
Barr et al.
Arch Intern Med 2002;162:1761-1768.
ABSTRACT | FULL TEXT  

Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
Herrington et al.
Circulation 2002;105:2962-2967.
ABSTRACT | FULL TEXT  

A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
Tsuyuki et al.
Arch Intern Med 2002;162:1149-1155.
ABSTRACT | FULL TEXT  

Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT | FULL TEXT  

A Community-Wide Survey of Physician Practices and Attitudes Toward Cholesterol Management in Patients With Recent Acute Myocardial Infarction
Yarzebski et al.
Arch Intern Med 2002;162:797-804.
ABSTRACT | FULL TEXT  

Impact of a Targeted Intervention on Lipid-Lowering Therapy in Patients With Coronary Artery Disease in the Hospital Setting
Lacy et al.
Arch Intern Med 2002;162:468-473.
ABSTRACT | FULL TEXT  

Supplemental Insurance and Use of Effective Cardiovascular Drugs Among Elderly Medicare Beneficiaries With Coronary Heart Disease
Federman et al.
JAMA 2001;286:1732-1739.
ABSTRACT | FULL TEXT  

Prevention and Treatment of Coronary Heart Disease: Who Benefits?
LaRosa
Circulation 2001;104:1688-1692.
ABSTRACT | FULL TEXT  

Presidential address: quality of cardiovascular care in the U.S.
Beller
J Am Coll Cardiol 2001;38:587-594.
FULL TEXT  

Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey
Qureshi et al.
Arch Intern Med 2001;161:1621-1628.
ABSTRACT | FULL TEXT  

Cardiovascular Disease and Dyslipidemia in Women
Welty
Arch Intern Med 2001;161:514-522.
ABSTRACT | FULL TEXT  

Use and Monitoring of "Statin" Lipid-Lowering Drugs Compared With Guidelines
Abookire et al.
Arch Intern Med 2001;161:53-58.
ABSTRACT | FULL TEXT  

Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction : Data From the National Registry of Myocardial Infarction 3
Fonarow et al.
Circulation 2001;103:38-44.
ABSTRACT | FULL TEXT  

Statins: underused by those who would benefit
Hulley et al.
BMJ 2000;321:971-972.
FULL TEXT  

Sexual Orientation and Health: Comparisons in the Women's Health Initiative Sample
Valanis et al.
Arch Fam Med 2000;9:843-853.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Cardiac Prevention Response
Abramson et al.
Circulation 2000;101:e223-224.
FULL TEXT  

The Lipid Treatment Assessment Project (L-TAP): A Multicenter Survey to Evaluate the Percentages of Dyslipidemic Patients Receiving Lipid-Lowering Therapy and Achieving Low-Density Lipoprotein Cholesterol Goals
Pearson et al.
Arch Intern Med 2000;160:459-467.
ABSTRACT | FULL TEXT  

Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada
Miller et al.
Arch Intern Med 2000;160:343-347.
ABSTRACT | FULL TEXT  

Blood Pressure Exceeding National Guidelines Among Women After Stroke
Kernan et al.
Stroke 2000;31:415-419.
ABSTRACT | FULL TEXT  

Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa et al.
JAMA 1999;282:2340-2346.
ABSTRACT | FULL TEXT  

The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
Goldman et al.
J Am Coll Cardiol 1999;34:768-776.
ABSTRACT | FULL TEXT  

Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines • Response
Danias et al.
Circulation 1999;99:3323-3326.
FULL TEXT  

Guide to Preventive Cardiology for Women
Mosca et al.
Circulation 1999;99:2480-2484.
FULL TEXT  

The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report
Bairey Merz et al.
J Am Coll Cardiol 1999;33:1453-1461.
ABSTRACT | FULL TEXT  

The National Cholesterol Education Program: Progress and Prospects
Cleeman and Lenfant
JAMA 1998;280:2099-2104.
ABSTRACT | FULL TEXT  

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease
Sbarouni et al.
J Am Coll Cardiol 1998;32:1244-1250.
ABSTRACT | FULL TEXT  

Time Trends in the Use of Cholesterol-Lowering Agents in Older Adults: The Cardiovascular Health Study
Lemaitre et al.
Arch Intern Med 1998;158:1761-1768.
ABSTRACT | FULL TEXT  

Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines
Frolkis et al.
Circulation 1998;98:851-855.
ABSTRACT | FULL TEXT  

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Hulley et al.
JAMA 1998;280:605-613.
ABSTRACT | FULL TEXT  

Comparing Generalist and Specialty Care: Discrepancies, Deficiencies, and Excesses
Donohoe
Arch Intern Med 1998;158:1596-1608.
ABSTRACT | FULL TEXT  

Atherosclerosis and the Immune System
Bittner
Arch Intern Med 1998;158:1395-1396.
FULL TEXT  

Primary Care Practice Adherence to National Cholesterol Education Program Guidelines for Patients With Coronary Heart Disease
McBride et al.
Arch Intern Med 1998;158:1238-1244.
ABSTRACT | FULL TEXT  

New Targeted AHA Research Program : Cardiovascular Care and Outcomes
Hill
Circulation 1998;97:1221-1222.
FULL TEXT  

Behavior and Biology: The Basic Sciences for AHA Action : Presented at the 70th Scientific Sessions of the American Heart Association November 9, 1997 Orlando, Florida
Hill
Circulation 1998;97:807-810.
FULL TEXT  

Behavior and Biology: The Basic Sciences for AHA Action : Presented at the 70th Scientific Sessions of the American Heart Association November 9, 1997 Orlando, Florida
Hill
Stroke 1998;29:739-742.
FULL TEXT  

Cholesterol Management in Theory and Practice
Gotto
Circulation 1997;96:4424-4430.
ABSTRACT | FULL TEXT  

Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association
Mosca et al.
Circulation 1997;96:2468-2482.
FULL TEXT  

Women Undertreated for Hypercholesterolemia
Journal Watch Cardiology 1997;1997:5-5.
FULL TEXT  

GUIDELINES FOR SECONDARY PREVENTION OF CHD NOT FOLLOWED IN WOMEN
JWatch General 1997;1997:3-3.
FULL TEXT  

Guidelines for Secondary CHD Prevention Not Met in Women
JWatch Women's Health 1997;1997:6-6.
FULL TEXT